EDGAR·FLOW

Adagio Medical Holdings, Inc. — Form 8-K

Filed November 16, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 78/100
What the filing says
Adagio Medical (market cap ~$7M) reported Q3 2026 with zero revenue, operating losses of $4.4M, and cash of $3.1M (down from $17.1M at year-end 2025). A $23M noncash gain from convertible note fair-value revaluation drove reported net income of $17.8M, but diluted EPS was negative $5.13. The Board initiated a formal process to explore strategic alternatives. The company effected a 1-for-30 reverse stock split on November 6, 2026 to regain Nasdaq compliance. Clinical progress includes 22 patients treated with vCLAS Ultra System and ongoing FDA PMA review.
Why this rating

Strategic review signals distress for micro-cap with 9-month cash runway at current burn; noncash gains mask operational deterioration; reverse split is compliance red flag.

Tradability signal
NO TRADE

No trade: negative news, but this cell's evidence is too weak. Similar past filings (342 in this cell) moved -1.08% in the called direction over 4 hrs; shrunk for sample size that's a -1.00% edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
at our read · unknown
$1.82
+10 min · unknown
$1.97 ▲ 7.97%
+30 min · unknown
$1.96 ▲ 7.69%
+1 hr · unknown
$1.82 ▲ 0.00%
+4 hrs · unknown
$1.75 ▼ 4.12%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ADGM · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.